Invesco’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Buy |
117,500
+87,551
| +292% | +$1.53M | ﹤0.01% | 2570 |
|
|
2025
Q1 | $377K | Buy |
29,949
+9,961
| +50% | +$125K | ﹤0.01% | 3256 |
|
|
2024
Q4 | $211K | Sell |
19,988
-105,623
| -84% | -$1.11M | ﹤0.01% | 3487 |
|
|
2024
Q3 | $1.82M | Sell |
125,611
-294,964
| -70% | -$4.28M | ﹤0.01% | 2636 |
|
|
2024
Q2 | $3.58M | Buy |
420,575
+9,203
| +2% | +$78.3K | ﹤0.01% | 2344 |
|
|
2024
Q1 | $4.2M | Buy |
411,372
+396,817
| +2,726% | +$4.06M | ﹤0.01% | 2334 |
|
|
2023
Q4 | $79.8K | Buy |
14,555
+1,698
| +13% | +$9.31K | ﹤0.01% | 3703 |
|
|
2023
Q3 | $48.6K | Buy |
12,857
+80
| +0.6% | +$302 | ﹤0.01% | 3783 |
|
|
2023
Q2 | $85.6K | Sell |
12,777
-234,212
| -95% | -$1.57M | ﹤0.01% | 3741 |
|
|
2023
Q1 | $1.61M | Buy |
246,989
+56,127
| +29% | +$365K | ﹤0.01% | 2717 |
|
|
2022
Q4 | $1.63M | Buy |
+190,862
| New | +$1.63M | ﹤0.01% | 2710 |
|